109 related articles for article (PubMed ID: 8813621)
1. 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
Friedrichs GS; Abreu JN; Black SC; Chi L; Lucchesi BR
Eur J Pharmacol; 1996 Jun; 306(1-3):99-106. PubMed ID: 8813621
[TBL] [Abstract][Full Text] [Related]
2. MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
Friedrichs GS; Chi L; Gralinski MR; Black SC; Basler GC; Mu DX; Pewitt SR; Johnson CR; Lucchesi BR
J Cardiovasc Pharmacol; 1995 Feb; 25(2):314-23. PubMed ID: 7752658
[TBL] [Abstract][Full Text] [Related]
3. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Black SC; Butterfield JL; Lucchesi BR
J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
[TBL] [Abstract][Full Text] [Related]
4. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Friedrichs GS; Abreu JN; Driscoll EM; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol; 1998 Jan; 31(1):56-66. PubMed ID: 9456278
[TBL] [Abstract][Full Text] [Related]
5. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death.
Chi L; Uprichard AC; Lucchesi BR
J Cardiovasc Pharmacol; 1990 Mar; 15(3):452-64. PubMed ID: 1691370
[TBL] [Abstract][Full Text] [Related]
6. HBI-3000 prevents secondary sudden cardiac death.
Lee JY; Lucchesi BR
J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
[TBL] [Abstract][Full Text] [Related]
7. Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death.
Friedrichs GS; Abreu JN; Cousins GR; Chi L; Borlak J; Lucchesi BR
J Cardiovasc Pharmacol Ther; 1996 Oct; 1(4):313-324. PubMed ID: 10684432
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
Chi LG; Mu DX; Lucchesi BR
J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
[TBL] [Abstract][Full Text] [Related]
9. Relevance of inter- and intraventricular electrical dispersion to arrhythmogenesis in normal and ischaemic rabbit myocardium: a study with cromakalim, 5-hydroxydecanoate and glibenclamide.
Wolk R; Cobbe SM; Kane KA; Hicks MN
J Cardiovasc Pharmacol; 1999 Feb; 33(2):323-34. PubMed ID: 10028944
[TBL] [Abstract][Full Text] [Related]
10. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
[TBL] [Abstract][Full Text] [Related]
11. Antifibrillatory effects of clofilium in the rabbit isolated heart.
Friedrichs GS; Chi L; Green AL; Lucchesi BR
Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
Fiedler VB; Mardin M
Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
Fryer RM; Hsu AK; Nagase H; Gross GJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):451-7. PubMed ID: 10900218
[TBL] [Abstract][Full Text] [Related]
14. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
Black SC; Chi LG; Mu DX; Lucchesi BR
J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
16. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
[TBL] [Abstract][Full Text] [Related]
17. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
Lynch JJ; Coskey LA; Montgomery DG; Lucchesi BR
Am Heart J; 1985 May; 109(5 Pt 1):949-58. PubMed ID: 3993529
[TBL] [Abstract][Full Text] [Related]
18. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs.
Billman GE; Kang JX; Leaf A
Circulation; 1999 May; 99(18):2452-7. PubMed ID: 10318669
[TBL] [Abstract][Full Text] [Related]
19. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
Auchampach JA; Grover GJ; Gross GJ
Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of sarcolemmal and mitochondrial K(ATP) channels activated by 17 beta-estradiol on reperfusion arrhythmias and infarct sizes in canine hearts.
Tsai CH; Su SF; Chou TF; Lee TM
J Pharmacol Exp Ther; 2002 Apr; 301(1):234-40. PubMed ID: 11907179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
